The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States
Open accessAbstract
Aerobic glycolysis, also referred to as the Warburg effect, has been regarded as the dominant metabolic phenotype in cancer cells for a long time. More recently, it has been shown that mitochondria in most tumors are not defective in their ability to carry out oxidative phosphorylation (OXPHOS). Instead, in highly aggressive cancer cells, mitochondrial energy pathways are reprogrammed to meet the challenges of high energy demand, better utilization of available fuels and macromolecular synthesis for rapid cell division and migration. Mitochondrial energy reprogramming is also involved in the regulation of oncogenic pathways via mitochondria-to-nucleus retrograde signaling and post-translational modification of oncoproteins. In addition, neoplastic mitochondria can engage in crosstalk with the tumor microenvironment. For example, signals from cancer-associated fibroblasts can drive tumor mitochondria to utilize OXPHOS, a process known as the reverse Warburg effect. Emerging evidence shows that cancer cells can acquire a hybrid glycolysis/OXPHOS phenotype in which both glycolysis and OXPHOS can be utilized for energy production and biomass synthesis. The hybrid glycolysis/OXPHOS phenotype facilitates metabolic plasticity of cancer cells and may be specifically associated with metastasis and therapy-resistance. Moreover, cancer cells can switch their metabolism phenotypes in response to external stimuli for better survival. Taking into account the metabolic heterogeneity and plasticity of cancer cells, therapies targeting cancer metabolic dependency in principle can be made more effective.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Due to the enhanced understanding of the importance and variability of cancer metabolism, metabolic reprogramming has attained the status of a hallmark of cancer [5,6].”
BackgroundOxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · cited 2×
“Fourth, the hybrid metabolic phenotype may be specifically associated with metastasis [9,10,12,90,135], as discussed before.”
BackgroundCancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · cited 3×
“c-Src [10], MAPK [46], AMPK [75], PARPs [76,77], and SIRT1 [66,77] are examples of proteins that can be modified by the mitochondrial signaling.”
BackgroundMetabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Figueroa, M. E., Abdel-Wahab, O., Lu, C., Ward, P. S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H. F., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.11.015 · Cited by 2,766
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Shibue, T., & Weinberg, R. A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.44 · Cited by 2,539
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.013 · Cited by 2,441
Understanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648 · cited 2×
“c-Src [10], MAPK [46], AMPK [75], PARPs [76,77], and SIRT1 [66,77] are examples of proteins that can be modified by the mitochondrial signaling.”
BackgroundHuman Cells Lacking mtDNA: Repopulation with Exogenous Mitochondria by Complementation
King, M. P., & Attardi, G. (1989) · Science · doi:10.1126/science.2814477 · Cited by 1,611
ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis
Ishikawa, K., Takenaga, K., Akimoto, M., Koshikawa, N., Yamaguchi, A., Imanishi, H., Nakada, K., Honma, Y., & Hayashi, J.-I. (2008) · Science · doi:10.1126/science.1156906 · Cited by 1,444
LeBleu, V. S., O’Connell, J. T., Gonzalez Herrera, K. N., Wikman, H., Pantel, K., Haigis, M. C., de Carvalho, F. M., Damascena, A., Domingos Chinen, L. T., Rocha, R. M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3039 · Cited by 1,404
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation
(1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90040-d · Cited by 1,387
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
HIF-1: upstream and downstream of cancer metabolism
Semenza, G. L. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.10.009 · Cited by 1,372
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138
Liu, S., Cong, Y., Wang, D., Sun, Y., Deng, L., Liu, Y., Martin-Trevino, R., Shang, L., McDermott, S. P., Landis, M. D., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.11.009 · Cited by 1,053
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035
Mitonuclear protein imbalance as a conserved longevity mechanism
Houtkooper, R. H., Mouchiroud, L., Ryu, D., Moullan, N., Katsyuba, E., Knott, G., Williams, R. W., & Auwerx, J. (2013) · Nature · doi:10.1038/nature12188 · Cited by 1,035
A mitochondrial specific stress response in mammalian cells
Zhao, Q., Wang, J., Levichkin, I. V., Stasinopoulos, S., Ryan, M. T., & Hoogenraad, N. J. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf445 · Cited by 1,026
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science · doi:10.1126/science.1174229 · Cited by 914
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899 · cited 1×
“Mitochondrial signals include but are not limited to ROS [63,64], Acetyl-CoA [10,65], NAD+/NADH ratio [66,67], calcium [68,69], ATP [10,70], and oncometabolites [71–74].”
BackgroundButow, R. A., & Avadhani, N. G. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00179-0 · Cited by 882
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
Davis, C. F., Ricketts, C. J., Wang, M., Yang, L., Cherniack, A. D., Shen, H., Buhay, C., Kang, H., Kim, S. C., Fahey, C. C., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.014 · Cited by 842
Self-citationFacile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids
Fliss, M. S., Usadel, H., Caballero, O. L., Wu, L., Buta, M. R., Eleff, S. M., Jen, J., & Sidransky, D. (2000) · Science · doi:10.1126/science.287.5460.2017 · Cited by 820
Superoxide is the major reactive oxygen species regulating autophagy
Chen, Y., Azad, M. B., & Gibson, S. B. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.49 · Cited by 796
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
Tan, A. S., Baty, J. W., Dong, L.-F., Bezawork-Geleta, A., Endaya, B., Goodwin, J., Bajzikova, M., Kovarova, J., Peterka, M., Yan, B., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.003 · Cited by 785
PARP-2, A Novel Mammalian DNA Damage-dependent Poly(ADP-ribose) Polymerase
Amé, J.-C., Rolli, V., Schreiber, V., Niedergang, C., Apiou, F., Decker, P., Muller, S., Höger, T., Murcia, J. M.-D., & de Murcia, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17860 · Cited by 745
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.015 · Cited by 722
Metabolic Reprogramming: the Emerging Concept and Associated Therapeutic Strategies
Yoshida, G. J. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0221-y · Cited by 716
Vazquez, F., Lim, J.-H., Chim, H., Bhalla, K., Girnun, G., Pierce, K., Clish, C. B., Granter, S. R., Widlund, H. R., Spiegelman, B. M., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.020 · Cited by 715
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Jolly, M. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00155 · Cited by 693
Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
Roesch, A., Vultur, A., Bogeski, I., Wang, H., Zimmermann, K. M., Speicher, D., Körbel, C., Laschke, M. W., Gimotty, P. A., Philipp, S. E., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.003 · Cited by 670 · cited 1×
“Consistently, OXPHOS inhibitors decrease the prevalence of BRAF inhibitor-resistant slow-cycling melanoma cells [119].”
BackgroundAcetylation of non-histone proteins modulates cellular signalling at multiple levels
Spange, S., Wagner, T., Heinzel, T., & Krämer, O. H. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.027 · Cited by 664
Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
Sciacovelli, M., Gonçalves, E., Johnson, T. I., Zecchini, V. R., da Costa, A. S. H., Gaude, E., Drubbel, A. V., Theobald, S. J., Abbo, S. R., Tran, M. G. B., et al. (2016) · Nature · doi:10.1038/nature19353 · Cited by 584
Mitochondrial-nuclear communications
Ryan, M. T., & Hoogenraad, N. J. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.052305.091720 · Cited by 575
A Mitochondrial Switch Promotes Tumor Metastasis
Porporato, P. E., Payen, V. L., Pérez-Escuredo, J., De Saedeleer, C. J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.043 · Cited by 571
Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis
Rasola, A., & Bernardi, P. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.04.007 · Cited by 563
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Dupuy, F., Tabariès, S., Andrzejewski, S., Dong, Z., Blagih, J., Annis, M. G., Omeroglu, A., Gao, D., Leung, S., Amir, E., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.08.007 · Cited by 558
Mitochondrial DNA copy number variation across human cancers
Reznik, E., Miller, M. L., Şenbabaoğlu, Y., Riaz, N., Sarungbam, J., Tickoo, S. K., Al-Ahmadie, H. A., Lee, W., Seshan, V. E., Hakimi, A. A., et al. (2016) · eLife · doi:10.7554/elife.10769 · Cited by 530
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Camarda, R., Zhou, A. Y., Kohnz, R. A., Balakrishnan, S., Mahieu, C., Anderton, B., Eyob, H., Kajimura, S., Tward, A., Krings, G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4055 · Cited by 528
Imagable 4T1 model for the study of late stage breast cancer
Tao, K., Fang, M., Alroy, J., & Sahagian, G. G. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-228 · Cited by 525
Heteroplasmic mitochondrial DNA mutations in normal and tumour cells
He, Y., Wu, J., Dressman, D. C., Iacobuzio-Donahue, C., Markowitz, S. D., Velculescu, V. E., Diaz Jr, L. A., Kinzler, K. W., Vogelstein, B., & Papadopoulos, N. (2010) · Nature · doi:10.1038/nature08802 · Cited by 524
MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination
Lu, M., Jolly, M. K., Levine, H., Onuchic, J. N., & Ben-Jacob, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318192110 · Cited by 487
Self-citationLamb, R., Ozsvari, B., Lisanti, C. L., Tanowitz, H. B., Howell, A., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.3174 · Cited by 478
Peiris-Pagès, M., Martinez-Outschoorn, U. E., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0712-6 · Cited by 465
Zhang, J., Tian, X.-J., Zhang, H., Teng, Y., Li, R., Bai, F., Elankumaran, S., & Xing, J. (2014) · Science Signaling · doi:10.1126/scisignal.2005304 · Cited by 462
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Janiszewska, M., Suvà, M. L., Riggi, N., Houtkooper, R. H., Auwerx, J., Clément-Schatlo, V., Radovanovic, I., Rheinbay, E., Provero, P., & Stamenkovic, I. (2012) · Genes & Development · doi:10.1101/gad.188292.112 · Cited by 452
Stability of the hybrid epithelial/mesenchymal phenotype
Jolly, M. K., Tripathi, S. C., Jia, D., Mooney, S. M., Celiktas, M., Hanash, S. M., Mani, S. A., Pienta, K. J., Ben-Jacob, E., & Levine, H. (2016) · Oncotarget · doi:10.18632/oncotarget.8166 · Cited by 436
Self-citationMitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64264 · Cited by 433
Oncometabolites: linking altered metabolism with cancer
Yang, M., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 422
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
Gaude, E., & Frezza, C. (2016) · Nature Communications · doi:10.1038/ncomms13041 · Cited by 375
Liao, J., Qian, F., Tchabo, N., Mhawech-Fauceglia, P., Beck, A., Qian, Z., Wang, X., Huss, W. J., Lele, S. B., Morrison, C. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084941 · Cited by 364
Bierie, B., Pierce, S. E., Kroeger, C., Stover, D. G., Pattabiraman, D. R., Thiru, P., Liu Donaher, J., Reinhardt, F., Chaffer, C. L., Keckesova, Z., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618298114 · Cited by 338
Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells
Suen, D.-F., Narendra, D. P., Tanaka, A., Manfredi, G., & Youle, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914569107 · Cited by 337
Metabolic Reprogramming of Cancer-Associated Fibroblasts by IDH3α Downregulation
Zhang, D., Wang, Y., Shi, Z., Liu, J., Sun, P., Hou, X., Zhang, J., Zhao, S., Zhou, B. P., & Mi, J. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.006 · Cited by 333
The Mitochondrial Genotype Can Influence Nuclear Gene Expression in Yeast
Parikh, V. S., Morgan, M. M., Scott, R., Clements, L. S., & Butow, R. A. (1987) · Science · doi:10.1126/science.3027892 · Cited by 324
Park, J. H., Vithayathil, S., Kumar, S., Sung, P.-L., Dobrolecki, L. E., Putluri, V., Bhat, V. B., Bhowmik, S. K., Gupta, V., Arora, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.004 · Cited by 313
Self-citationKetogenic diets as an adjuvant cancer therapy: History and potential mechanism
Allen, B. G., Bhatia, S. K., Anderson, C. M., Eichenberger-Gilmore, J. M., Sibenaller, Z. A., Mapuskar, K. A., Schoenfeld, J. D., Buatti, J. M., Spitz, D. R., & Fath, M. A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.08.002 · Cited by 312
SR/ER–mitochondrial local communication: Calcium and ROS
Csordás, G., & Hajnóczky, G. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.06.004 · Cited by 308
TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development
Yang, M.-H., & Wu, K.-J. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6324 · Cited by 295
Pastò, A., Bellio, C., Pilotto, G., Ciminale, V., Silic-Benussi, M., Guzzo, G., Rasola, A., Frasson, C., Nardo, G., Zulato, E., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2010 · Cited by 293
Zhang, L., Huang, G., Li, X., Zhang, Y., Jiang, Y., Shen, J., Liu, J., Wang, Q., Zhu, J., Feng, X., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-108 · Cited by 293
In Vivo Correction of COX Deficiency by Activation of the AMPK/PGC-1α Axis
Viscomi, C., Bottani, E., Civiletto, G., Cerutti, R., Moggio, M., Fagiolari, G., Schon, E. A., Lamperti, C., & Zeviani, M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.011 · Cited by 292
Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes
Robertson-Tessi, M., Gillies, R. J., Gatenby, R. A., & Anderson, A. R. A. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1428 · Cited by 279
Yu, L., Lu, M., Jia, D., Ma, J., Ben-Jacob, E., Levine, H., Kaipparettu, B. A., & Onuchic, J. N. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2074 · Cited by 272
Self-citationCiavardelli, D., Rossi, C., Barcaroli, D., Volpe, S., Consalvo, A., Zucchelli, M., De Cola, A., Scavo, E., Carollo, R., D'Agostino, D., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.285 · Cited by 269
Tumors and Mitochondrial Respiration: A Neglected Connection
Viale, A., Corti, D., & Draetta, G. F. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0491 · Cited by 266
Amuthan, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.8.1910 · Cited by 262
De Luca, A., Fiorillo, M., Peiris-Pagès, M., Ozsvari, B., Smith, D. L., Sanchez-Alvarez, R., Martinez-Outschoorn, U. E., Cappello, A. R., Pezzi, V., Lisanti, M. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4401 · Cited by 259
über den Stoffwechsel der Carcinomzelle
Warburg, O. (1925) · Klinische Wochenschrift · doi:10.1007/bf01726151 · Cited by 253
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
Zhou, Y., Zhou, Y., Shingu, T., Feng, L., Chen, Z., Ogasawara, M., Keating, M. J., Kondo, S., & Huang, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260935 · Cited by 250
Cheong, J.-H., Park, E. S., Liang, J., Dennison, J. B., Tsavachidou, D., Nguyen-Charles, C., Wa Cheng, K., Hall, H., Zhang, D., Lu, Y., et al. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0497 · Cited by 245
Survival Outcomes in Cancer Patients Predicted by a Partial EMT Gene Expression Scoring Metric
George, J. T., Jolly, M. K., Xu, S., Somarelli, J. A., & Levine, H. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3521 · Cited by 244
Self-citationMitochondrial Genetic Background Modifies Breast Cancer Risk
Bai, R.-K., Leal, S. M., Covarrubias, D., Liu, A., & Wong, L.-J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3554 · Cited by 241
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta-Grigoriou, F. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 240
Witkiewicz, A. K., Whitaker-Menezes, D., Dasgupta, A., Philp, N. J., Lin, Z., Gandara, R., Sneddon, S., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19530 · Cited by 239
Dihydropyrimidine Accumulation Is Required for the Epithelial-Mesenchymal Transition
Shaul, Y. D., Freinkman, E., Comb, W. C., Cantor, J. R., Tam, W. L., Thiru, P., Kim, D., Kanarek, N., Pacold, M. E., Chen, W. W., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.032 · Cited by 222
Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
Jiang, L., Xiao, L., Sugiura, H., Huang, X., Ali, A., Kuro-o, M., Deberardinis, R. J., & Boothman, D. A. (2015) · Oncogene · doi:10.1038/onc.2014.321 · Cited by 221
Bonuccelli, G., Whitaker-Menezes, D., Castello-Cros, R., Pavlides, S., Pestell, R. G., Fatatis, A., Witkiewicz, A. K., Vander Heiden, M. G., Migneco, G., Chiavarina, B., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11601 · Cited by 220
Guha, M., & Avadhani, N. G. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.08.007 · Cited by 216
Farnie, G., Sotgia, F., & Lisanti, M. P. (2015) · Oncotarget · doi:10.18632/oncotarget.5401 · Cited by 205
Fructose-1,6-bisphosphate couples glycolytic flux to activation of Ras
Peeters, K., Van Leemputte, F., Fischer, B., Bonini, B. M., Quezada, H., Tsytlonok, M., Haesen, D., Vanthienen, W., Bernardes, N., Gonzalez-Blas, C. B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01019-z · Cited by 203
Acin-Perez, R., Gatti, D. L., Bai, Y., & Manfredi, G. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.03.024 · Cited by 190 · cited 1×
“Mitochondrial signals include but are not limited to ROS [63,64], Acetyl-CoA [10,65], NAD+/NADH ratio [66,67], calcium [68,69], ATP [10,70], and oncometabolites [71–74].”
BackgroundCytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies
Wilkins, H., Carl, S. M., & Swerdlow, R. H. (2014) · Redox Biology · doi:10.1016/j.redox.2014.03.006 · Cited by 185
Oncometabolites: Unconventional triggers of oncogenic signalling cascades
Sciacovelli, M., & Frezza, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.025 · Cited by 178
Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors
Desouki, M. M., Kulawiec, M., Bansal, S., Das, G. C., & Singh, K. K. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2233 · Cited by 176
Chou, C.-C., Lee, K.-H., Lai, I.-L., Wang, D., Mo, X., Kulp, S. K., Shapiro, C. L., & Chen, C.-S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0135 · Cited by 170
Diminished tumorigenic phenotype after depletion of mitochondrial DNA.
Cavalli, L. R., Varella‐Garcia, M., & Liang, B. C. (1997) · PubMed · Cited by 157
Metabolic differences in breast cancer stem cells and differentiated progeny
Vlashi, E., Lagadec, C. H., Vergnes, L., Reue, K., Frohnen, P., Chan, M., Alhiyari, Y. M., Dratver, M. B., & Pajonk, F. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3051-2 · Cited by 156
Morandi, A., Taddei, M. L., Chiarugi, P., & Giannoni, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00040 · Cited by 156
Lu, C., Qin, L., Liu, H.-C., Candas, D., Fan, M., & Li, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121046 · Cited by 154
Migneco, G., Whitaker-Menezes, D., Chiavarina, B., Castello-Cros, R., Pavlides, S., Pestell, R. G., Fatatis, A., Flomenberg, N., Tsirigos, A., Howell, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11989 · Cited by 153
Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
Arcucci, A., Ruocco, M. R., Granato, G., Sacco, A. M., & Montagnani, S. (2016) · BioMed Research International · doi:10.1155/2016/4502846 · Cited by 152
Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling
Colacino, J. A., Azizi, E., Brooks, M. D., Harouaka, R. A., Fouladdel, S., McDermott, S., Lee, M., Hill, D., Madden, J. M., Boerner, J. L., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.001 · Cited by 148
Lamb, R., Bonuccelli, G., Ózsvári, B., Peiris‐Pagès, M., Fiorillo, M., Smith, D. L., Bevilacqua, G., Mazzanti, C. M., McDonnell, L. A., Naccarato, A. G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5852 · Cited by 146
Sun, Y., Daemen, A., Hatzivassiliou, G., Arnott, D. P., WILSON, C. A., Zhuang, G., Gao, M., Liu, P. J., Boudreau, A., Johnson, L., et al. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-20 · Cited by 140
Bordbar, A., Yurkovich, J. T., Paglia, G., Rolfsson, Ó., Sigurjónsson, Ó. E., & Palsson, B. Ø. (2017) · Scientific Reports · doi:10.1038/srep46249 · Cited by 134
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer
Witkiewicz, A. K., Dasgupta, A., Nguyen, K., Liu, C., Kovatich, A. J., Schwartz, G. F., Pestell, R. G., Sotgia, F., Rui, H., & Lisanti, M. P. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8874 · Cited by 128
The Yeast Retrograde Response as a Model of Intracellular Signaling of Mitochondrial Dysfunction
Jazwinski, S. M., & Kriete, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00139 · Cited by 126
Sotgia, F., Galdo, F. D., Casimiro, M. C., Bonuccelli, G., Mercier, I., Whitaker‐Menezes, D., Daumer, K. M., Zhou, J., Wang, C., Katiyar, S., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080658 · Cited by 125
Yang, L., Hou, Y., Yuan, J., Tang, S., Zhang, H., Zhu, Q., Du, Y.-E., Zhou, M., Wen, S., Xu, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4697 · Cited by 121
Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism
Zielinski, D. C., Jamshidi, N., Corbett, A. J., Bordbar, A., Thomas, A., & Palsson, B. Ø. (2017) · Scientific Reports · doi:10.1038/srep41241 · Cited by 117
Colvin, H. S., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., Hata, T., Kawamoto, K., Asai, A., Tsunekuni, K., et al. (2016) · Scientific Reports · doi:10.1038/srep36289 · Cited by 116
The complex crosstalk between mitochondria and the nucleus: What goes in between?
Cagin, U., & Enríquez, J. A. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.01.026 · Cited by 115
(1994) · PubMed · Cited by 109
Sub-Sets of Cancer Stem Cells Differ Intrinsically in Their Patterns of Oxygen Metabolism
Gammon, L., Biddle, A., Heywood, H. K., Johannessen, A. C., & Mackenzie, I. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062493 · Cited by 100
Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory
Jia, D., Jolly, M. K., Kulkarni, P., & Levine, H. (2017) · Cancers · doi:10.3390/cancers9070070 · Cited by 99
Self-citationKaipparettu, B. A., Ma, Y., Park, J. H., Lee, T., Zhang, Y., Yotnda, P., Creighton, C. J., Chan, W., & Wong, L. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061747 · Cited by 95
Self-citationTargeting Mitochondrial Metabolism by Inhibiting Autophagy in BRAF-Driven Cancers
Strohecker, A. M., & White, E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0196 · Cited by 89
Distinguishing mechanisms underlying EMT tristability
Jia, D., Jolly, M. K., Tripathi, S. C., den Hollander, P., Huang, B., Lu, M., Çeliktaş, M., Ramirez‐Peña, E., Ben‐Jacob, E., Onuchic, J. N., et al. (2017) · Cancer Convergence · doi:10.1186/s41236-017-0005-8 · Cited by 84
Self-citationAccessorizing the human mitochondrial transcription machinery
Bestwick, M. L., & Shadel, G. S. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2013.03.006 · Cited by 82
Mechanistic characterization of the thioredoxin system in the removal of hydrogen peroxide
Pannala, V. R., & Dash, R. K. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.10.508 · Cited by 81
Kulawiec, M., Owens, K. M., & Singh, K. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.89 · Cited by 81
Quantifying the underlying landscape and paths of cancer
Li, C., & Wang, J. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.0774 · Cited by 74
Mitochondrial DNA Content Varies with Pathological Characteristics of Breast Cancer
Bai, R., Chang, J., Yeh, K., Lou, M. A., Lu, J., Tan, D., Liu, H., & Wong, L. C. (2011) · Journal of Oncology · doi:10.1155/2011/496189 · Cited by 72
Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential
Feeley, K. P., Bray, A. W., Westbrook, D. G., Johnson, L. W., Kesterson, R. A., Ballinger, S. W., & Welch, D. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0074 · Cited by 72
Hayashi, J., Takemitsu, M., & Nonaka, I. (1992) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01233159 · Cited by 70
Performance of mitochondrial DNA mutations detecting early stage cancer
Jakupciak, J. P., Maragh, S., Markowitz, M. E., Greenberg, A. K., Hoque, M. O., Maitra, A., Barker, P. E., Wagner, P. D., Rom, W. N., Srivastava, S., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-285 · Cited by 70
Lin, C.-S., Lee, H.-T., Lee, S.-Y., Shen, Y., Wang, L.-S., Chen, Y.-J., & Wei, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911228 · Cited by 64
Comparing the yeast retrograde response and NF‐κB stress responses: implications for aging
Srinivasan, V., Kriete, A., Saçan, A., & Jazwinski, S. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00622.x · Cited by 60
Arnold, I., Wagner-Ecker, M., Ansorge, W. J., & Langer, T. (2006) · Gene · doi:10.1016/j.gene.2005.09.044 · Cited by 57
Essential Role for Oxidative Phosphorylation in Cancer Progression
Maiuri, M. C., & Kroemer, G. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.013 · Cited by 56
Guha, M., Srinivasan, S., Biswas, G., & Avadhani, N. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611693200 · Cited by 54
Expression of ganglioside GD2, reprogram the lipid metabolism and EMT phenotype in bladder cancer
Vantaku, V., Donepudi, S. R., Ambati, C. R., Jin, F., Putluri, V., Nguyen, K., Rajapakshe, K., Coarfa, C., Battula, V. L., Lotan, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21038 · Cited by 53
Tu, Y., Kaipparettu, B. A., Ma, Y., & Wong, L.-J. C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.04.015 · Cited by 49
Self-citationKaipparettu, B. A., Ma, Y., & Wong, L. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05621.x · Cited by 45
Self-citationOXPHOS dysfunction regulates integrin- 1 modifications and enhances cell motility and migration
Nunes, J. B., Peixoto, J., Soares, P., Máximo, V., Carvalho, S., Pinho, S. S., Vieira, A. F., Paredes, J., Rego, A. C., Ferreira, I. L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu612 · Cited by 45
Farris, J. C., Pifer, P. M., Zheng, L., Gottlieb, E., Denvir, J., & Frisch, S. M. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0050 · Cited by 45
Brinker, A. E., Vivian, C. J., Koestler, D. C., Tsue, T. T., Jensen, R. A., & Welch, D. R. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-2194 · Cited by 38
Transmitochondrial Cybrids: Tools for Functional Studies of Mutant Mitochondria
Vithayathil, S. A., Ma, Y., & Kaipparettu, B. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-504-6_15 · Cited by 36
Self-citationChanges in mitochondrial function during EMT induced by TGFβ-1 in pancreatic cancer
Guo, Q. (2017) · Oncology Letters · doi:10.3892/ol.2017.5613 · Cited by 29
Walczak, J., Partyka, M., Duszyński, J., & Szczepanowska, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-14964-y · Cited by 19
The Nurture of Tumors Can Drive Their Metabolic Phenotype
Schug, Z. T., Voorde, J. V., & Gottlieb, E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.02.016 · Cited by 17
Cited by
Lipid metabolism reprogramming and its potential targets in cancer
Cheng, C., Geng, F., Cheng, X., & Guo, D. (2018) · Cancer Communications · doi:10.1186/s40880-018-0301-4 · Cited by 850
Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 591
Fatty Acid Synthase: An Emerging Target in Cancer
Fhu, C. W., & Ali, A. (2020) · Molecules · doi:10.3390/molecules25173935 · Cited by 392
The enhancement of glycolysis regulates pancreatic cancer metastasis
Yang, J., Ren, B., Yang, G., Wang, H., Chen, G., You, L., Zhang, T., & Zhao, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03278-z · Cited by 347
Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 336
Self-citation
Metadata
- Authors
- Jia, D., Park, J., Jung, K., Levine, H., & Kaipparettu, B.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2018-03-13
- Volume
- 7
- Issue
- 3
- Pages
- 21
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2793902970
- Cited by
- 270
- References
- 157
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.